Clinicopathologic effects of chronic reserpine administration in mongrel dogs.
D000284:Administration, Oral; D000311:Adrenal Glands / Q000187:drug effects / Q000473:pathology; D000818:Animals; D001663:Bilirubin / Q000494:pharmacology; D001786:Blood Glucose; D001806:Blood Urea Nitrogen; D001831:Body Temperature / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002319:Cardiovascular System / Q000503:physiopathology; D003967:Diarrhea / Q000139:chemically induced; D004285:Dogs; D004906:Erythrocyte Count; D005260:Female; D005951:Glucose Tolerance Test; D006400:Hematocrit; D006454:Hemoglobins / Q000494:pharmacology; D007421:Intestine, Small / Q000473:pathology; D007668:Kidney / Q000473:pathology; D007958:Leukocyte Count; D008099:Liver / Q000473:pathology; D008168:Lung / Q000473:pathology; D008297:Male; D008540:Meiosis; D009206:Myocardium / Q000473:pathology; D009541:Nictitating Membrane / Q000187:drug effects; D010053:Ovary / Q000473:pathology; D010902:Pituitary Gland / Q000473:pathology; D012110:Reserpine / Q000008:administration & dosage / Q000009:adverse effects*; D013737:Testis / Q000473:pathology
D001786:Blood Glucose; D006454:Hemoglobins; D012110:Reserpine; D001663:Bilirubin